Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hodgson

Showing results (331-340 of 8,972) with videos related to

Pageof 898
Sort By:
Bio/Technology (Nature Publishing Company)|February 1, 1992
Hypertexting through the regulationsJ Hodgson
Bio/Technology (Nature Publishing Company)|July 1, 1992
Sequencing and mapping efforts in "model organisms"J Hodgson
Nature Biotechnology|March 6, 2019
CRISPR target prediction remains blunt tool for clinical applicationsJohn Hodgson
Special Education: Forward Trends|March 1, 1984
Integrating physically handicapped pupilsA Hodgson
Bio/Technology (Nature Publishing Company)|January 1, 1993
Fetal bovine serum revisited. A year ago serum regulations were a hodgepodge. Has anything changed?J Hodgson
Bio/Technology (Nature Publishing Company)|June 1, 1993
Pharmaceutical screening: from off-the-wall to off-the-shelf. The many routes to successful drug discoveryJ Hodgson
Bio/Technology (Nature Publishing Company)|August 1, 1994
The changing bulk biocatalyst marketJ Hodgson
Occupational Medicine (Philadelphia, Pa.)|January 1, 1995
The medical evaluationM Hodgson
Science (New York, N.Y.)|March 27, 1992
Biotech's Chinese ConnectionG Hodgson
Science (New York, N.Y.)|June 28, 1991
Funding cutoff threatens thai scienceG Hodgson
Pageof 898

Showing results (331-340 of 8,972) with videos related to

Sort By:
Pageof 898
Bio/Technology (Nature Publishing Company)|February 1, 1992
Hypertexting through the regulationsJ Hodgson
Bio/Technology (Nature Publishing Company)|July 1, 1992
Sequencing and mapping efforts in "model organisms"J Hodgson
Nature Biotechnology|March 6, 2019
CRISPR target prediction remains blunt tool for clinical applicationsJohn Hodgson
Special Education: Forward Trends|March 1, 1984
Integrating physically handicapped pupilsA Hodgson
Bio/Technology (Nature Publishing Company)|January 1, 1993
Fetal bovine serum revisited. A year ago serum regulations were a hodgepodge. Has anything changed?J Hodgson
Bio/Technology (Nature Publishing Company)|June 1, 1993
Pharmaceutical screening: from off-the-wall to off-the-shelf. The many routes to successful drug discoveryJ Hodgson
Bio/Technology (Nature Publishing Company)|August 1, 1994
The changing bulk biocatalyst marketJ Hodgson
Occupational Medicine (Philadelphia, Pa.)|January 1, 1995
The medical evaluationM Hodgson
Science (New York, N.Y.)|March 27, 1992
Biotech's Chinese ConnectionG Hodgson
Science (New York, N.Y.)|June 28, 1991
Funding cutoff threatens thai scienceG Hodgson
Pageof 898